For the complete article, The Incretin Effect, and information on other aspects of GLP-1 treatment, please visit Novo Nordisk’s diabetesinamerica at www.novomedlink.com/diabetes/diabetes-in-america.
Read More »Diabetes In Control
Perspectives from Diabetes Thought Leaders on the Use of GLP-1 Agonists
Leading experts, Anne L. Peters, MD, Ralph A. DeFronzo, MD, Alan J. Garber, MD, PhD, Robert R. Henry, MD, Richard Bergenstal, MD, and others, share their thoughts on GLP-1 therapy….
Read More »New Vibe Insulin Pump with CGMS
New Vibe Insulin Pump with CGMS Animas’ Glucose-Monitoring Insulin Pump OK’d in Europe. Animas said it has received a CE Mark in Europe for its Animas Vibe product, which the company said is the first continuous glucose monitoring-enabled, waterproof insulin pump system for people with diabetes. The product is also the …
Read More »Low-fat Chocolate Milk Best for Post-exercise
Drinking low-fat chocolate milk after a tough workout provides the right mix of carbohydrates and high-quality protein, U.S. researchers found. Researchers in three related studies compared the recovery benefits of drinking low-fat chocolate milk after exercise to a carbohydrate beverage with the same calories — similar to a typical sports …
Read More »Prediabetes May Protect against Incontinence Symptoms
Researchers have unexpectedly found evidence that the early stages of metabolic syndrome, insulin resistance, and the accompanying hyperinsulinemia may have favorable effects on lower urinary tract symptoms (LUTS). After analyzing 34,000 men aged 30 and older, they discovered that metabolic syndrome seemed to protect against LUTS. They observed a "marginally …
Read More »Angiotensin Receptor Blockers (ARBs) — Drug Safety Review Completed
FDA’s meta-analysis of 31 randomized controlled trials comparing ARBs to other treatment found no evidence of an increased risk of incident (new) cancer, cancer-related death, breast cancer, lung cancer, or prostate cancer in patients receiving ARBs. FDA
Read More »HbA1C Test Poorly Predictive in Dialysis Patients
Conventional glucose control monitoring methods may not be as meaningful in diabetes patients with end-stage renal disease, researchers found. Patients on dialysis will normally show a lower A1c than they actually have, giving patients and physicians a false sense of security.… The Gold standard long-term glucose monitoring test for patients …
Read More »New Polypill Data Predicts a Halving of CV Events
The first randomized, placebo-controlled study of a polypill has suggested that use of such a product in primary prevention could bring about a halving of heart disease and stroke events….
Read More »Carbohydrate Counting Improves Glycemic Control for Type 1s
Carbohydrate quantification is an effective and safe strategy to manage glycemia and improve QoL.…
Read More »High-Fat Diet During Pregnancy Programs Child for Future Diabetes
A high-fat diet during pregnancy may program a woman’s baby for future diabetes, even if she herself is not obese or diabetic.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.